SCHEMBL6792936

SCHEMBL6792936

O=C(Nc1ccc(/C=C/c2nc3ccccc3[nH]2)cc1)c1ccccc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 12/20 0.67
MTOR P42345 1/20 0.50
HPSE Q9Y251 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HSP90AA1 P07900 1/20 0.45
PKM P14618 1/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
APOB P04114 1/20 0.44
MTTP P55157 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6792943 1.00 TRPV1 (0.67) TRPV1MTORHPSEKDM4EMEN1
SCHEMBL6793964 0.80 PKM (0.57) MTORHPSENPC1ALDH1A1PKM
SCHEMBL1796626 0.80 TRPV1 (0.85) TRPV1
SCHEMBL1796623 0.80 TRPV1 (0.85) TRPV1
SCHEMBL6801623 0.80 NTRK1 (0.62) TRPV1MTORALDH1A1
SCHEMBL1799519 0.79 TRPV1 (0.71) TRPV1
SCHEMBL1798933 0.79 TRPV1 (0.68) TRPV1
SCHEMBL1798936 0.79 TRPV1 (0.68) TRPV1
SCHEMBL6794927 0.78 NTRK1 (0.56) TRPV1MTORALDH1A1PKMSMN1; SMN2
SCHEMBL6794283 0.78 MTOR (0.58) MTORKDM4EMEN1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 TRPV1 3714/4885MTOR 3898/4885HPSE 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.